Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dormicum-Ketamine vs Dexmedetomidine for Emergence Delirium in Pediatric Burn Patients
NCT07519863Phase 2Recruiting
- Sponsor
- Ain Shams University
- Start
- Nov 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midazolam, ketamine, dexmedetomidine in emergence delirium (ED), sponsored by Ain Shams University. Started Nov 2025; status: recruiting.
02
Drugs
midazolamketaminedexmedetomidine
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT07519863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07519863.